NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Modulate Bio Inc.

Modulate Bio Inc.

Private
MassachusettsHealthcare & Life Scienceshttps://www.modulatebio.com/

Last Round

Seed Round

Apr 7, 2026

Total Funding Raised

$1.66M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Modulate Bio Inc. is a biotechnology company developing novel, differentiated GABAA positive allosteric modulators to treat neurological disorders including Essential Tremor, epilepsy, and anxiety.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule therapyGABA-A receptor modulatorsneurological disorderspreclinical biotechessential tremorepilepsy treatmentanxiety medicationdrug licensingbiotech pipelinemedicinal chemistrypharma partneringneuroscience startupCNS drugs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Modulate Bio Inc. Comps

Public and private peers based on sector, stage, and business model.

Modulate Bio Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Modulate Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 7, 2026
SeedJun 12, 2025
Pre SeedOct 23, 2024
GrantJan 1, 2024
AcceleratorDec 13, 2023
Grant
Sep 26, 2022

Key People

Founding team and executive leadership

Andrew Thomson

Ipsen BD I, CEO Co-founder

Founding Team

Modulate Bio Inc. Investors

Notable investors and investment history

Modulate Bio Inc. investors
InvestorRounds
Bija VenturesSeed Round, Seed
Harvard Innovation LabsGrant
Pillar VCSeed Round, Accelerator, Pre Seed, Seed
Blavatnik Fellowship in Life Science EntrepreneurshipGrant
NovaterraSeed Round, Pre Seed, Seed
NucleateAccelerator
Phoenix Investment ClubSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    $785K raised in Seed Round funding.

  • Jan 21, 2026

    Monthly visitors increased 856% MoM, from 131 to 1.3K.

Modulate Bio Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Modulate Bio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Modulate Bio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMassachusetts
Employee Range5
Year Founded2023
Last FundingApr 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.